Cite
HARVARD Citation
Atreya, R. et al. (n.d.). P554 Point of Care detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the biosimilar SB2: performance comparison with ELISA. Journal of Crohn's and colitis. p. S391. [Online].